Quinidine - serum
Last updated: Saturday, 20, March, 2004
MBS Online Search Page: Click here for details
| Item | Process |
|---|---|
| Specimen | 5 mL blood in plain tube, collected as trough level immediately prior to next dose. |
| Method | Chromatography, fluorometry, immunoassay. |
| Therapeutic Interval | 7-15 µmol/L (2.3-4.8 mg/L). |
| Application | 24 to 48 hours should elapse prior to retesting after dose adjustment. Mean half-life 7 hours (range 4-12 hours). |
| Interpretation | Level must be related to time since last dose. |
| Reference | Ochs HR et al. Clin Pharmacokinet 1980; 5: 150-168. |